This is a study to determine the safety and efficacy of liothyronine sodium/triiodothyronine (Triostat), a synthetic thyroid hormone, when given to infants with congenital heart disease during cardiopulmonary bypass surgery. Funding Source - FDA OOPD.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
220
Los Angeles Children's Hospital
Los Angeles, California, United States
Lucille Packard Children's Hospital
Palo Alto, California, United States
Seattle Children's Hospital
Seattle, Washington, United States
Time To Extubation
time on mechanical ventilation after aortic cross clamp removal
Time frame: 30 days
ICU Length of Stay
Length of stay in the ICU
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.